Melatonin: An antioxidant protects against cyclosporine-induced nephrotoxicity

Transplantation

Volumn 67, Issue 7, 1999, Pages 1065-1068

  Kumar, K Vijay ^a   Naidu, M U R ^a   Shifow, Anwar A ^a   Prayag, Aruna ^a   Ratnakar, K S ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CHLORIDE; CREATININE; CYCLOSPORIN; LITHIUM; MALONALDEHYDE; MELATONIN; POTASSIUM; SODIUM; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; HISTOPATHOLOGY; KIDNEY CALCIFICATION; KIDNEY CLEARANCE; MALE; NEPHROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; CALCINOSIS; CREATININE; CYCLOSPORINE; KIDNEY DISEASES; LITHIUM; MALE; MALONDIALDEHYDE; MELATONIN; NEPHRONS; RATS; RATS, WISTAR; UREA;

EID: 0033561406     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199904150-00022     Document Type: Article

References (17)

1. Mihatsh MJ, Ryffel B, Gudat F. The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 1995; 48: S63.
2. Ichikawa I, Kimaya S, Yoshioka T. Renal antioxidant enzymes: their regulation and function. Kidney Int 1994; 45: 1.
3. Wang C, Salahudeen AK. Cyclosporine nephrotoxicity attenuation by an antioxidant of lipid peroxidation in vitro and in vivo. Transplantation 1994; 58: 940.
4. Assis SMA, Monteiro JL, Seguro AC. L-Arginine and allopurinol protect against cyclosporine nephrotoxicity. Transplantation 1997; 63: 1070.
5. Tan D, Chen LD, Peoggeler B, Manchester LD, Reiter JR. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57.
6. Peoggeler B, Saarela S, Reiter JR, et al. Melatonin: a highly potent endogenous radical scavenger and electron donar; new aspects of its oxidation chemistry of this indole assessed in vivo. Ann NY Acad Sci 1994; 73: 419.
7. Montilla P, Tunez I, Lopez A, Soria JV. Hyperlipidemic nephropathy induced by adriamycin: effect of melatonin administration. Nephron 1997; 76: 345.
8. Whiting PH, Simpson JG. Lithium clearance measurements as an indicator of cyclosporine A nephrotoxicity in the rat. Clin Sci 1988; 74: 173.
9. Bernheim FM, Bernheim ML, Wilbur KM. The reaction between TBA and the oxidation products of certain lipids. J Biol Chem 1948; 174: 257.
10. Andoh TF, Burdmann EA, Fransechini, Houghton DC, Bennet WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK306. Kidney Int 1996; 50: 110.
11. Reiter RJ, Melchiorri D, Sewerynek K, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 1: 1.
12. Washio M, Nanishi F, Onoyama K, Fujishima M. Alpha-tocopherol improves focal glomerulosclerosis in rats with adriamycin-induced progressive renal failure. Nephron 1994; 68: 347.
13. Okasaro T, Takikawa T, Utsumomiya Y. Suppressive effect of superoxide dismutase on adriamycin nephrotoxicity. Nephron 1992; 60: 199.
14. Weekley LB. Influence of melatonin on bovine pulmonary vascular and bronchial airway smooth muscle tone. Clin Auton Res 1995; 5: 53.
15. Pentney PT, Bubenik GA. Melatonin reduces the severity of dextran-induced colitis in mice. J Pineal Res 1995; 19 (1): 31.
16. Andoh TF, Burdmann EA, Bennet WM. Nephrotoxicity of immunosuppressive drugs: experimental and clinical observations. Semin Nephrol 1997; 17 (1): 34.
17. Chen LD, Kumar P, Reiter RJ, et al. Melatonin prevents the suppression of cardiac Ca++ stimulated ATPase activity induced by alloxan. Am J Physiol 1994; 267: 57.